Glaxo's swine flu shot may give kids fever

Dec 04, 2009

(AP) -- The European Medicines Agency warns that young children given GlaxoSmithKline's swine flu shot may get a fever after their second dose.

In a statement issued Friday, the European drug regulator said data from PLC showed a higher number of aged six months to 3 years had a fever after their second dose of the Pandemrix vaccine, compared with the first. Kids were also more likely to have side effects like muscle pain, drowsiness, and irritability.

The European regulator recommends children get two doses of vaccine, though Glaxo says one dose is enough.

Glaxo's vaccine contains an adjuvant, a to boost the immune response. It is sold across Europe and Canada.

Another formulation of Glaxo's vaccine, without the adjuvant, is available in the U.S. Vaccines with adjuvants usually cause more side effects. No flu vaccines with adjuvants are licensed in the U.S.

Last month, Glaxo advised health authorities not to use one batch of its Canadian-manufactured swine flu vaccine in case it triggered life-threatening side effects like anaphylactic shock.

In a press briefing on Thursday, the World Health Organization's flu chief Keiji Fukuda said that more than 150 million doses of swine have been distributed in more than 40 countries and that they had not seen any evidence to suggest the vaccines caused worrying side effects.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: FDA to start regulating lab-developed tests

add to favorites email to friend print save as pdf

Related Stories

WHO approves Glaxo's swine flu shot

Dec 01, 2009

(AP) -- Drug giant GlaxoSmithKline says one of its swine flu vaccines has been certified by the World Health Organization, making it available for donors to buy for developing countries.

WHO: nearly 5,000 swine flu deaths worldwide

Oct 23, 2009

(AP) -- Nearly 5,000 people have reportedly died from swine flu since it emerged this year and developed into a global epidemic, the World Health Organization said Friday.

EU drug agency: License 2 swine flu vaccines

Sep 25, 2009

(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

WHO: Swine flu vaccine on track

Aug 06, 2009

(AP) -- Swine flu vaccine manufacturers are on track to start delivering the first batches of it in September, the World Health Organization said Thursday.

Recommended for you

FDA to start regulating lab-developed tests

1 minute ago

(AP)—The Food and Drug Administration says it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

User comments : 0